comparemela.com

Latest Breaking News On - கர்லா சல்கடோ - Page 1 : comparemela.com

Las mujeres representan el 57% de teletrabajadores

Las mujeres representan el 57% de teletrabajadores Facebook Social print Una teletrabajadora, en Guayaquil, dice que ha ahorrado tiempo y costos en el traslado. Foto: archivo / EL COMERCIO Diana Serrano y Priscilla Alvarado. Redactoras (I) En Ministerio del Trabajo. El número de mujeres pesa un 57% en el total de empleados que teletrabajan y se explica, en parte, porque la mayoría labora en enseñanza y la mayor parte de establecimientos sigue en clases virtuales. Otra razón es que esta modalidad ha permitido que puedan conciliar el trabajo con su vida familiar y el cuidado de sus hijos, en momentos en que las clases siguen suspendidas. Ahora, por el

Many concerns raised in Latin America, hard hit by COVID-19

Many concerns raised in Latin America, hard hit by COVID-19
brownsvilleherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from brownsvilleherald.com Daily Mail and Mail on Sunday newspapers.

COVID-19 vaccines, Latin America

By Patrick J. McDonnell and Kate Linthicum Los Angeles Times/TNS MEXICO CITY  -  In Latin America, a region hard hit by pandemic, poverty and flawed health care systems, many experts fear that large-scale coronavirus immunization campaigns could prove a logistical nightmare, even as vaccinations are set to begin. Home to 8.4 percent of the global population, Latin America and the Caribbean account for 30 percent of the world’s 1.6 million COVID-19 deaths and 19 percent of the 76 million COVID-19 infections, according to data from Johns Hopkins University and the World Bank. Mexico and Chile plan to start inoculating health workers by month’s end with the vaccine developed by U.S.-based Pfizer Inc. and its German partner, BioNTech, which is already in use in the United States and Britain. Other Latin American countries are unveiling ambitious plans for large-scale immunization campaigns employing varying vaccines, most still in the testing stage - and virtually all devel

As corona vaccine rollout nears, many concerns are raised in hard-hit Latin America

By PATRICK J. MCDONNELL AND KATE LINTHICUM | Los Angeles Times | Published: December 21, 2020 Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription. MEXICO CITY (Tribune News Service) In Latin America, a region hard hit by pandemic, poverty and flawed health care systems, many experts fear that large-scale coronavirus immunization campaigns could prove a logistical nightmare, even as vaccinations are set to begin. Home to 8.4% of the global population, Latin America and the Caribbean account for 30% of the world’s 1.6 million COVID-19 deaths and 19% of the 76 million COVID-19 infections, according to data from Johns Hopkins University and the World Bank.

As vaccine rollout nears, many concerns raised in Latin America, hard hit by COVID-19 [Los Angeles Times]

As vaccine rollout nears, many concerns raised in Latin America, hard hit by COVID-19 [Los Angeles Times] In Latin America, a region hard hit by pandemic, poverty and flawed healthcare systems, many experts fear that large-scale coronavirus immunization campaigns could prove a logistical nightmare, even as vaccinations are set to begin. Home to 8.4% of the global population, Latin America and the Caribbean account for 30% of the world’s 1.6 million COVID-19 deaths and 19% of the 76 million COVID-19 infections, according to data from Johns Hopkins University and the World Bank. Mexico and Chile plan to start inoculating health workers by month’s end with the vaccine developed by U.S.-based Pfizer Inc. and its German partner, BioNTech, which is already in use in the United States and Britain. Other Latin American countries are unveiling ambitious plans for large-scale immunization campaigns employing varying vaccines, most still in the testing stage and virtually all developed

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.